Clas Nyberg

Education

Nyberg studied law at Lund University from 1979 to 1984 and obtained a Bachelor of Laws degree. During his university years, he was active in Västgöta Nation, serving as klubbmästare and prokurator.

Career

Clas Nyberg has worked as a partner at Mannheimer & Zetterlöf and subsequently at Mannheimer Swartling Advokatbyrå. His practice has included business law and mergers and acquisitions. He led Mannheimer Swartling teams advising on the 2010 sale of Volvo to Geely and AstraZeneca’s 2011 divestment of Astra Tech to DENTSPLY. In the Astra Tech transaction, the team advised AstraZeneca on the sale of the dental and medical-products company in a transaction valued at approximately 1.8 billion U.S. dollars. Nyberg was also a member of Mannheimer Swartling’s board of directors from 2011, according to the firm’s 2013 annual report.

Achievements

• Led Mannheimer Swartling’s legal team advising on Geely’s 2010 acquisition of Volvo.

• Led Mannheimer Swartling’s legal team advising AstraZeneca on the 2011 divestment of Astra Tech to DENTSPLY in a transaction valued at approximately 1.8 billion U.S. dollars.

Membership

While studying at Lund University, Nyberg participated in Västgöta Nation and held the student leadership roles of klubbmästare and prokurator. He also served as a member of Mannheimer Swartling’s board of directors from 2011.

• Held the student leadership roles of klubbmästare and prokurator while studying at Lund University.

  Västgöta Nation , Sweden

  1979 - 1984

References

• Mannheimer Swartling: Mannheimer Swartling rådger AstraZeneca vid avyttring av Astra Tech för 1,8 miljarder dollar Documents Nyberg’s leadership of Mannheimer Swartling’s legal team advising AstraZeneca on the sale of Astra Tech.
  2011
• Dagens Juridik: Mannheimer biträdde vid försäljningen av Volvo Documents Nyberg’s role as one of the leaders of Mannheimer Swartling’s team advising on Volvo’s sale to Geely.
  2010
• Mannheimer Swartling Annual Report 2013 Identifies Nyberg as a partner and member of Mannheimer Swartling’s board of directors from 2011.
  2013